Peter G. Traber
2013 - Galectin Therapeutics
In 2013, Peter G. Traber earned a total compensation of $612.7K as Chief Executive Officer & President at Galectin Therapeutics, a 44% decrease compared to previous year.
Compensation breakdown
| Bonus | $194,688 |
|---|---|
| Salary | $375,000 |
| Other | $43,002 |
| Total | $612,690 |
Traber received $375K in salary, accounting for 61% of the total pay in 2013.
Traber also received $194.7K in bonus and $43K in other compensation.
Rankings
In 2013, Peter G. Traber's compensation ranked 8,640th out of 12,286 executives tracked by ExecPay. In other words, Traber earned more than 29.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,640 out of 12,286 | 30th |
Division Manufacturing | 3,143 out of 4,612 | 32nd |
Major group Chemicals And Allied Products | 993 out of 1,462 | 32nd |
Industry group Drugs | 753 out of 1,156 | 35th |
Industry Pharmaceutical Preparations | 598 out of 890 | 33rd |
Source: SEC filing on November 10, 2016.
Traber's colleagues
We found three more compensation records of executives who worked with Peter G. Traber at Galectin Therapeutics in 2013.